Literature DB >> 11469692

Microvessel density in pituitary adenomas and carcinomas.

S Vidal1, K Kovacs, E Horvath, B W Scheithauer, T Kuroki, R V Lloyd.   

Abstract

Tumor growth depends on several factors, including angiogenesis. Tumors cannot grow if new vessels are not formed to supply the cells with oxygen and other nutrients and to remove waste products. Increased angiogenesis can be correlated with tumor growth and metastatic potential in many tumor types, indicating that neoformation of vessels is a prognostic indicator of tumor behavior. We evaluated microvessel densities in 157 various pituitary adenoma types and seven pituitary carcinomas using immunocytochemistry for CD-34 antigen, a reliable marker of endothelial cells. The lowest percentage of microvessel density was found in growth hormone-producing adenomas, the highest level in pituitary carcinomas. In general, no major correlation was found between MIB-1 index (an indicator of cell proliferation) and microvessel density. The statistical study also demonstrated no gender-dependent changes in the microvessel density of pituitary tumors. Although the microvessel density was not significantly different in relation to invasiveness of pituitary tumors, our results demonstrate a tendency of invasive pituitary tumors to be more highly vascularized than non-invasive ones. Dopamine agonist and long-acting somatostatin analog treatment compared with untreated tumors did not significantly affect microvessel densities. Statistical differences were demonstrated in the microvessel density of macroadenomas between patients older and patients younger than 40 years. Significant differences were also apparent in the microvessel densities between microadenomas and macroadenomas diagnosed in young patients but not in the older age group. The strongly positive correlation observed between microvessel density and age is consistent with the view that age of the host may have an influence on the extent of neovascularization of pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469692     DOI: 10.1007/s004280000373

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  33 in total

1.  Vascularization of rat pituitary autografts.

Authors:  Matilde Lombardero; Andres Quintanar-Stephano; Sergio Vidal; Eva Horvath; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  J Anat       Date:  2006-05       Impact factor: 2.610

2.  Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors.

Authors:  Matilde Lombardero; Sergio Vidal; Robert Hurta; Alba Román; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 3.  Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue.

Authors:  Antonio Di Ieva; Fabio Grizzi; Paolo Gaetani; Umberto Goglia; Manfred Tschabitscher; Pietro Mortini; Riccardo Rodriguez y Baena
Journal:  Neurosurg Rev       Date:  2008-03-08       Impact factor: 3.042

4.  VEGF and CD31 association in pituitary adenomas.

Authors:  Carolina Cristina; María Inés Perez-Millan; Guillermina Luque; Raúl Ariel Dulce; Gustavo Sevlever; Silvia Inés Berner; Damasia Becu-Villalobos
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

Review 5.  Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour.

Authors:  N Garcia de la Torre; H E Turner; J A H Wass
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

6.  Angiogenesis and the growth potential of craniopharyngiomas.

Authors:  Sergio Vidal; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 7.  Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas.

Authors:  Mansur E Shomali; Laurence Katznelson
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

8.  Prolactin-producing pituitary adenoma associated with prolactin cell hyperplasia.

Authors:  Sergio Vidal; Eva Horvath; Luis V Syro; Humberto Uribe; Sandy Cohen; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

9.  Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumors.

Authors:  Abby J Sarkar; Kirti Chaturvedi; Cui Ping Chen; Dipak K Sarkar
Journal:  J Endocrinol       Date:  2007-02       Impact factor: 4.286

10.  Enhanced nestin expression and small blood vessels in human pituitary adenomas.

Authors:  María Inés Perez-Millan; Silvia Inés Berner; Guillermina María Luque; Cristian De Bonis; Gustavo Sevlever; Damasia Becu-Villalobos; Carolina Cristina
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.